AT341312T - An oral pharmaceutical sustained release composition - Google Patents

An oral pharmaceutical sustained release composition

Info

Publication number
AT341312T
AT341312T AT03291180T AT03291180T AT341312T AT 341312 T AT341312 T AT 341312T AT 03291180 T AT03291180 T AT 03291180T AT 03291180 T AT03291180 T AT 03291180T AT 341312 T AT341312 T AT 341312T
Authority
AT
Austria
Prior art keywords
sustained release
release composition
oral pharmaceutical
pharmaceutical sustained
oral
Prior art date
Application number
AT03291180T
Other languages
German (de)
Inventor
Sandrine Salle
Emmanuel Guerin
Original Assignee
Ethypharm Sa
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa, Toray Industries filed Critical Ethypharm Sa
Priority to EP03291180A priority Critical patent/EP1479383B1/en
Publication of AT341312T publication Critical patent/AT341312T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
AT03291180T 2003-05-20 2003-05-20 An oral pharmaceutical sustained release composition AT341312T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP03291180A EP1479383B1 (en) 2003-05-20 2003-05-20 Oral sustained release pharmaceutical composition

Publications (1)

Publication Number Publication Date
AT341312T true AT341312T (en) 2006-10-15

Family

ID=33041114

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03291180T AT341312T (en) 2003-05-20 2003-05-20 An oral pharmaceutical sustained release composition

Country Status (9)

Country Link
US (1) US9616071B2 (en)
EP (1) EP1479383B1 (en)
JP (1) JP5013871B2 (en)
CN (1) CN100475197C (en)
AT (1) AT341312T (en)
CA (1) CA2525542C (en)
DE (1) DE60308828T2 (en)
ES (1) ES2272914T3 (en)
WO (1) WO2004103350A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2897267A1 (en) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formulations for oral administration multimicroparticulate
DE102006035549A1 (en) * 2006-07-27 2008-01-31 Evonik Röhm Gmbh Dosage form with at least two-layer separating layer
EP2127643A1 (en) * 2008-05-30 2009-12-02 Bayer Schering Pharma Aktiengesellschaft Oral pellet composition with time-delayed release
EP2198859A1 (en) 2008-12-17 2010-06-23 Losan Pharma GmbH Melt-coated pharmaceutical composition with fast release
FR2959130A1 (en) * 2010-04-21 2011-10-28 Sanofi Aventis Process for preparing pharmaceutical compositions for oral administration comprising one or more active ingredients and compositions comprising same
JP5780775B2 (en) 2011-02-18 2015-09-16 株式会社Lttバイオファーマ Nanoparticles containing prostaglandin i2 derivative
CN103127220B (en) * 2011-12-05 2014-12-31 上海中医药大学 Moisture-proof coating method used for traditional Chinese medicine salvia miltiorrhiza extract powder or particles
EP2925303A4 (en) * 2012-11-30 2016-04-27 Insmed Inc Prostacylin compositions and methods for using the same
US20170049739A1 (en) 2013-10-25 2017-02-23 Insmed Incorporated Prostacyclin compounds, compositions and methods of use thereof
EP3221291A4 (en) 2014-11-18 2018-06-27 Insmed Incorporated Methods of manufacturing treprostinil and treprostinil derivative prodrugs

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0419210B2 (en) * 1982-07-26 1992-03-30 Shinetsu Chem Ind Co
FI101344B1 (en) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co A process for preparing a preparation for which the controlled release of a pharmaceutically active agent
JPH01287019A (en) * 1988-05-12 1989-11-17 Tanabe Seiyaku Co Ltd Slowly releasing drug preparation
JPH01287021A (en) * 1988-05-13 1989-11-17 Shin Etsu Chem Co Ltd Preparation of wax-coated drug preparation
JPH02225416A (en) * 1989-02-28 1990-09-07 Toray Ind Inc Oral pharmaceutical containing 5,6,7-tolynol-4,8-inter-m-phenylene pgi2 derivative
US5405617A (en) * 1991-11-07 1995-04-11 Mcneil-Ppc, Inc. Aliphatic or fatty acid esters as a solventless carrier for pharmaceuticals
JPH05309314A (en) * 1992-05-07 1993-11-22 Sumitomo Pharmaceut Co Ltd Coating method
IL110014A (en) 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
JP3471977B2 (en) * 1995-06-02 2003-12-02 信越化学工業株式会社 Enteric formulations coated without solvent enteric coating agents using a liquid plasticizer
US20010003588A1 (en) * 1996-09-12 2001-06-14 Smithkline Beecham Corporation Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2.]oct-3-yl)acetonitrile monohydrochloride
PT947196E (en) * 1997-03-14 2009-09-24 Toray Industries Sustained-release prostaglandin i derivative preparation
DE19808634A1 (en) 1998-02-24 1999-08-26 Schering Ag Production of pharmaceutical pellets, especially containing iloprost, with stabilized release properties
JP2000103732A (en) 1998-07-28 2000-04-11 Tanabe Seiyaku Co Ltd Intestinal right place release preparation
DE60137943D1 (en) * 2000-08-31 2009-04-23 Jagotec Ag milled particles
US6620439B1 (en) * 2000-10-03 2003-09-16 Atul M. Mehta Chrono delivery formulations and method of use thereof
EP1413294B1 (en) * 2001-07-27 2010-09-29 Astellas Pharma Inc. Composition comprising sustained-release fine particles for quick-disintegrating tablets in the buccal cavity
US7125563B2 (en) * 2002-04-12 2006-10-24 Dava Pharmaceuticals, Inc. Sustained release pharmaceutical preparations and methods for producing the same

Also Published As

Publication number Publication date
EP1479383B1 (en) 2006-10-04
CA2525542C (en) 2012-01-10
US20070269506A1 (en) 2007-11-22
JP5013871B2 (en) 2012-08-29
CN1791390A (en) 2006-06-21
CN100475197C (en) 2009-04-08
DE60308828T2 (en) 2007-05-24
CA2525542A1 (en) 2004-12-02
ES2272914T3 (en) 2007-05-01
DE60308828D1 (en) 2006-11-16
EP1479383A1 (en) 2004-11-24
JP2006528969A (en) 2006-12-28
US9616071B2 (en) 2017-04-11
WO2004103350A1 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
DK1651296T3 (en) medicament dispenser
RU2005127353A (en) Rapid pharmaceutical composition
DE60237087D1 (en) Pharmaceutical compositions for the coordinated release of NSAID
DE60330135D1 (en) Folate receptor-directed imaging conjugates
AT356618T (en) Abuse-proofed dosage form
DE60309383D1 (en) Silver-containing dental composition
DK1287822T3 (en) Oral pharmaceutical controlled release mesalazinsammensætninger
AT419835T (en) Nystatin nanoparticle compositions
NO20043723L (en) Pharmaceutical dosage forms for avgivese through mucous membranes
DE60005819D1 (en) A taste masked oral pharmaceutical compositions with controlled release
AT479752T (en) therapeutic compositions
DE60315795D1 (en) A pharmaceutical composition comprising valsartan and NEP-inhibitors
DE602005009327D1 (en) Dihydrotetrabenazine and pharmaceutical compositions containing them
DK1545467T3 (en) Solid pharmaceutical formulations comprising telmisartan
DK1755552T3 (en) Oral Care Film
DE602006009656D1 (en) 1-a (3-hydroxy-adamant-1-ylamino) -acetylü-pyrrolidin-2 (S) -carbonitrile-modified release formulation
NO20033384L (en) Pharmaceutical formulations
NO20033556L (en) pharmaceutical formulations
AT291922T (en) Makrolidcitrat-containing formulations with controlled release
NO20034551D0 (en) Ball releasing device
DE60142197D1 (en) A pharmaceutical composition
AT532556T (en) Medicines elutionselektrode
AT380544T (en) Coated solid dosage form in
RU2005111222A (en) oral formulations
DK1553929T3 (en) Composition having controlled release.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties